Pharmacokinetics and drug interactions of medications used to treat hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantation-Reference-Cited by-同舟云学术

Pharmacokinetics and drug interactions of medications used to treat hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantation

Published:2018-04 Issue: Volume:22 Page:S22-S35
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:Hemodialysis International

Author:

Ortiz Guillermo A.¹,Trivedi Hirsh D.²,Nader Claudia³

Affiliation:

1. Department of Medicine; St. Elizabeth's Medical Center, Tufts University School of Medicine; Boston Massachusetts USA

2. Liver Center, Beth Israel Deaconess Medical Center, Harvard Medical School; Boston Massachusetts USA

3. Division of Infectious Diseases, Department of Medicine; St. Elizabeth's Medical Center, Tufts University School of Medicine; Boston Massachusetts USA

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hdi.12648/fullpdf

Reference65 articles.

1. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence;Mohd Hanafiah;Hepatology.,2013

2. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS;Fissell;Kidney Int.,2004

3. Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans;Molnar;Hepatology.,2015

4. eGFR decrease during antiviral C therapy with first generation protease inhibitors: A clinical significance?;Loustaud-Ratti;Liver Int.,2015

5. Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir;Mauss;Hepatology.,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The risk of solid organ tumors in patients with chronic kidney disease: A narrative review of literature;Heliyon;2024-07

2. Effects of comorbid conditions and prescribed chronic medications on the treatment plan for chronic hepatitis C infection: A cross‐sectional retrospective study;Health Science Reports;2024-04-29

3. Comparative Survival Analysis of Dialysis and Renal Transplantation in HBV-Infected End-Stage Renal Disease Patients;Transplantation Proceedings;2023-12

4. Outcomes of short‐duration antiviral prophylaxis for hepatitis C positive donor kidney transplants;American Journal of Transplantation;2021-07-26

5. 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations;Journal of the Formosan Medical Association;2020-07